BTAI vs PCG · rev $388.0K vs P/E 13, rev $12.78B
BioXcel Therapeutics Inc (BTAI) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported PCG revenue for 2026-06-30 was $12.78B. Net income was $1.65B. Revenue was up 85.8% from 2026-03-31 to 2026-06-30. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
BTAI currently screens at market cap $36.1M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the BTAI and PCG stock pages for the full models.
Not investment advice.